`
`
`Paper No. _____
`Filed: March 14, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________________
`
`MODERNA THERAPEUTICS, INC.,
`Petitioner,
`
`v.
`
`PROTIVA BIOTHERAPEUTICS, INC.,
`Patent Owner.
`_____________________________
`
`Case IPR2018-00739
`Patent No. 9,364,435
`_____________________________
`
`
`PATENT OWNER PROTIVA BIOTHERAPEUTICS, INC.’S
`MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2018-00739
`Patent 9,364,435
`A. Real Party-In-Interest
`
`
`
`In accordance with 37 C.F.R. § 42.8(b)(1), Patent Owner identifies Arbutus
`
`Biopharma Corporation (fka “Tekmira”) as the real party-in-interest. Protiva
`
`Biotherapeutics, Inc. existed as a wholly-owned subsidiary of Arbutus Biopharma
`
`Corporation. Protiva Biotherapeuitics, Inc. was amalgamated into Arbutus
`
`Biopharma Corporation in January 2018.
`
`B. Related Matters
`
`
`
`In accordance with 37 C.F.R. § 42.8(b)(2), Patent Owner identifies the
`
`following related matter:
`
`
`
`Moderna Therapeutics, Inc. v. Protiva Biotherapeutics, Inc., IPR2018-00680
`
`regarding U.S. Patent No. 9,404,127.
`
`C. Lead and Back-up Counsel
`
`
`
`In accordance with 37 C.F.R. § 42.8(b)(3), Patent Owner provides the
`
`following designation of counsel:
`
`Lead Counsel
`Michael T. Rosato
`USPTO Reg. No. 52,182
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2529
`Fax: 206-883-2699
`Email: mrosato@wsgr.com
`
`
`Back-Up Counsel
`Steven W. Parmelee
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Email: sparmelee@wsgr.com
`
`-2-
`
`
`
`Case IPR2018-00739
`Patent 9,364,435
`
`
`
`
`
`Back-Up Counsel
`Sonja R. Gerrard
`USPTO Reg. No. 72,802
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2649
`Fax: 206-883-2699
`Email: sgerrard@wsgr.com
`
`D. Electronic Service
`
`Patent Owner consents to electronic service by email at the email addresses
`
`provided above.
`
`
`
`Date: March 14, 2018
`
`
`
`Respectfully submitted,
`
`
`/ Michael T. Rosato /
`Michael T. Rosato, Lead Counsel
`Reg. No. 52,182
`
`
`
`
`
`
`
`-3-
`
`
`
`Case IPR2018-00739
`Patent 9,364,435
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that the foregoing Patent Owner Protiva
`
`Biotherapeutics, Inc.’s Mandatory Notices Under 37 C.F.R. § 42.8 and
`
`accompanying Power of Attorney were served on March 14, 2018, at the following
`
`electronic service addresses:
`
`
`
`Michael Fleming
`C. Maclain Wells
`Alan Heinrich
`IRELL & MANELLA LLP
`mfleming@irell.com
`mwells@irell.com
`aheinrich@irell.com
`ModernaIPR@irell.com
`
`
`Date: March 14, 2018
`
`
`
`
`
`
`/ Michael T. Rosato /
`Michael T. Rosato, Lead Counsel
`Reg. No. 52,182
`
`
`
`
`
`-4-
`
`